Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

terephthalylidene dicamphor sulfonic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
terephthalylidene dicamphor sulfonic acid
Unique ID
C075352
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C075352
Entry Term(s)
3,3'-(1,4-phenylenedimethylidyne)bis(7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methanesulfonic acid)
Ecamsule
Mexoryl SX
Pharm Action
Sunscreening Agents
Registry Numbers
0
92761-26-7
Related Numbers
92761-26-7
CAS Type 1 Name
((3Z)-3-((4-((Z)-(7,7-dimethyl-3-oxo-4-(sulfomethyl)norbornan-2-ylidene)methyl)phenyl)methylidene)-7,7-dimethyl-2-oxo-norbornan-1-yl)methanesulfonic acid
Previous Indexing
CAMPHOR/*AA (1992-2006)
*MESYLATES (1992-2006)
Heading Mapped to
*Camphanes
*Sulfonic Acids
Frequency
21
Note
structure given in first source; abreviated as TDSA; FDA approved 2006 as component of Anthelios SX along with avobenzone and octocrylene
Source
Photochem Photobiol 1992 Apr;55(4):549-60
Date of Entry
1992/07/28
Revision Date
2006/07/26
terephthalylidene dicamphor sulfonic acid Preferred
3,3'-(1,4-phenylenedimethylidyne)bis(7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methanesulfonic acid) Broader
Mexoryl SX Narrower
Ecamsule Narrower
page delivered in 0.007s